Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0403
0.00 (0.00%)
At close: Mar 2, 2026

Entia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2016 FY 2015 FY 2014 FY 2013 FY 2012 2011 - 2007
Period Ending
Feb '26 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12 2011 - 2007
Market Capitalization
123354
Upgrade
Market Cap Growth
510.61%-39.83%-7.81%-40.38%28.04%12.37%
Upgrade
Enterprise Value
-23354
Upgrade
Last Close Price
0.040.060.090.200.600.50
Upgrade
PS Ratio
5.175.947.554.3315.1410.08
Upgrade
PB Ratio
-0.70-0.80-3.31-24.38-5.02-5.74
Upgrade
EV/Sales Ratio
-8.018.005.2316.5011.21
Upgrade
Debt / Equity Ratio
-0.53-0.53-0.35-3.73-0.44-0.70
Upgrade
Net Debt / Equity Ratio
-0.49-0.49-0.32-2.87-0.41-0.68
Upgrade
Net Debt / EBITDA Ratio
-0.84-0.84-0.13-0.19-0.15-0.42
Upgrade
Net Debt / FCF Ratio
-1.36-1.36-0.47-0.49-0.47-1.34
Upgrade
Asset Turnover
0.600.600.530.870.570.85
Upgrade
Inventory Turnover
1.661.662.972.630.970.70
Upgrade
Quick Ratio
0.040.040.030.350.030.07
Upgrade
Current Ratio
0.110.110.100.440.140.22
Upgrade
Return on Assets (ROA)
-164.37%-164.37%-181.53%-147.40%-306.38%-155.65%
Upgrade
Return on Capital Employed (ROCE)
70.10%70.10%242.20%1519.60%282.40%167.20%
Upgrade
Earnings Yield
-101.68%-88.55%-86.28%-80.83%-65.15%-33.96%
Upgrade
FCF Yield
--45.37%-20.79%-24.10%-17.19%-8.91%
Upgrade
Buyback Yield / Dilution
-15.84%-15.84%-157.24%-25.34%-3.22%-16.62%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.